{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:34:40Z","timestamp":1791441280479,"version":"4.3.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ymgme.2023.107651","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T13:02:52Z","timestamp":1689253372000},"page":"107651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Phenotypic characterisation of the Mucopolysaccharidosis Type I (MPSI) Idua-W392X mouse model reveals increased anxiety-related traits in female mice"],"prefix":"10.1016","volume":"139","author":[{"given":"Tereza","family":"Andreou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ishikawa-Learmonth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W","family":"Bigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ymgme.2023.107651_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymgme.2016.01.011","article-title":"Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres","volume":"117","author":"Ghosh","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107651_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"issue":"40","key":"10.1016\/j.ymgme.2023.107651_bb0015","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.2174\/1381612826666200724161504","article-title":"Therapeutic options for Mucopolysaccharidosis II (hunter disease)","volume":"26","author":"Kubaski","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ymgme.2023.107651_bb0020","series-title":"GeneReviews((R)). Seattle (WA)","article-title":"Mucopolysaccharidosis Type I","author":"Clarke LA","year":"1993"},{"issue":"3","key":"10.1016\/j.ymgme.2023.107651_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijns6030072","article-title":"Current practices for U.S. newborn screening of Pompe disease and MPSI","volume":"6","author":"Ames","year":"2020","journal-title":"Int. J. Neonatal. Screen"},{"issue":"1","key":"10.1016\/j.ymgme.2023.107651_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200519010-00001","article-title":"Laronidase treatment of mucopolysaccharidosis I","volume":"19","author":"Wraith","year":"2005","journal-title":"BioDrugs"},{"issue":"3","key":"10.1016\/j.ymgme.2023.107651_bb0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14656566.6.3.489","article-title":"The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I","volume":"6","author":"Wraith","year":"2005","journal-title":"Expert. Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107651_bb0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/bjh.13059","article-title":"Transplantation in inborn errors of metabolism: current considerations and future perspectives","volume":"167","author":"Boelens","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107651_bb0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2011.10.005","article-title":"The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse","volume":"105","author":"Wang","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107651_bb0050","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1038\/s41467-021-24443-8","article-title":"In utero adenine base editing corrects multi-organ pathology in a lethal lysosomal storage disease","volume":"12","author":"Bose","year":"2021","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.ymgme.2023.107651_bb0055","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","article-title":"Hematopoietic stem- and progenitor-cell gene therapy for hurler syndrome","volume":"385","author":"Gentner","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107651_bb0060","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2010.265","article-title":"Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and hurler syndromes","volume":"19","author":"Ellinwood","year":"2011","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107651_bb0065","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1038\/s41467-019-11962-8","article-title":"Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I","volume":"10","author":"Gomez-Ospina","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2023.107651_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12615","article-title":"Advances in therapies for neurological lysosomal storage disorders","author":"Ellison","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107651_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/mgme.1999.2860","article-title":"Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats","volume":"67","author":"He","year":"1999","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.ymgme.2023.107651_bb0080","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1203\/00006450-197911000-00018","article-title":"Alpha-L-iduronidase deficiency in a cat: a model of mucopolysaccharidosis I","volume":"13","author":"Haskins","year":"1979","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107651_bb0085","first-page":"244","article-title":"Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I","volume":"109","author":"Shull","year":"1982","journal-title":"Am. J. Pathol."},{"issue":"19","key":"10.1016\/j.ymgme.2023.107651_bb0090","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1073\/pnas.80.19.6091","article-title":"A canine model of human alpha-L-iduronidase deficiency","volume":"80","author":"Spellacy","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ymgme.2023.107651_bb0095","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0888-7543(05)80182-X","article-title":"Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I","volume":"14","author":"Menon","year":"1992","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.ymgme.2023.107651_bb0100","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107651_bb0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2023.107651_bb0110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcmd.2015.12.008","article-title":"No evidence for cell activation or brain vaso-occlusion with plerixafor mobilization in sickle cell mice","volume":"57","author":"Choi","year":"2016","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107651_bb0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2009.08.002","article-title":"Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation","volume":"99","author":"Wang","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107651_bb0120","first-page":"3","article-title":"Characterization of the MPS I-H knock-in mouse reveals increased femoral biomechanical integrity with compromised material strength and altered bone geometry","volume":"5","author":"Oestreich","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107651_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0166-4328(94)90008-6","article-title":"Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions","volume":"61","author":"Simon","year":"1994","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107651_bb0130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jneumeth.2011.10.001","article-title":"Noninvasive in vivo assessment of muscle impairment in the mdx mouse model--a comparison of two common wire hanging methods with two different results","volume":"203","author":"Klein","year":"2012","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ymgme.2023.107651_bb0135","article-title":"Measuring the strength of mice","volume":"76","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107651_bb0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbr.2012.04.051","article-title":"Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice","volume":"233","author":"Baldo","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymgme.2023.107651_bb0145","article-title":"Use of the open field maze to measure locomotor and anxiety-like behavior in mice","volume":"96","author":"Seibenhener","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"4","key":"10.1016\/j.ymgme.2023.107651_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10545-010-9079-5","article-title":"Clinical aspects of neuropathic lysosomal storage disorders","volume":"33","author":"Jardim","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107651_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020262","article-title":"Temporal appearance of enhanced innate anxiety in Alzheimer model mice","volume":"11","author":"Szabo","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymgme.2023.107651_bb0160","article-title":"A longitudinal study of neurocognition and behavior in patients with hurler-Scheie syndrome heterozygous for the L238Q mutation","volume":"20","author":"Ahmed","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2023.107651_bb0165","first-page":"75","article-title":"Social functioning and behaviour in Mucopolysaccharidosis IH [hurlers syndrome]","volume":"39","author":"Lehtonen","year":"2018","journal-title":"JIMD Rep."},{"issue":"10","key":"10.1016\/j.ymgme.2023.107651_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025717","article-title":"Female mucopolysaccharidosis IIIA mice exhibit hyperactivity and a reduced sense of danger in the open field test","volume":"6","author":"Langford-Smith","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ymgme.2023.107651_bb0175","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1601-183X.2011.00706.x","article-title":"Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments","volume":"10","author":"Langford-Smith","year":"2011","journal-title":"Genes Brain Behav."},{"issue":"2","key":"10.1016\/j.ymgme.2023.107651_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172435","article-title":"Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II","volume":"12","author":"Gleitz","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2023.107651_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nbd.2015.02.006","article-title":"Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells","volume":"76","author":"Jiang","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2023.107651_bb0190","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuroscience.2007.03.051","article-title":"Phenotypic characterization of spatial cognition and social behavior in mice with \u2018knockout\u2019 of the schizophrenia risk gene neuregulin 1","volume":"147","author":"O\u2019Tuathaigh","year":"2007","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.ymgme.2023.107651_bb0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1101\/lm.89805","article-title":"Working memory deficits in retinoid X receptor gamma-deficient mice","volume":"12","author":"Wietrzych","year":"2005","journal-title":"Learn. Mem."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:54:32Z","timestamp":1761090872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223002810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1096719223002810"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107651","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic characterisation of the Mucopolysaccharidosis Type I (MPSI) Idua-W392X mouse model reveals increased anxiety-related traits in female mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107651"}}